Ebitda Margins

Bank of Baroda Q3 results: Net profit rises 5.6% to Rs 4,837 crore, NII up 3%. L&T Q3 results: Net profit rises 14% to Rs 3,359 crore, but misses estimates as EBITDA margins fall. Biocon Q3 results: All business segments grow; EBITDA up 16%, revenue rises 7%. IndusInd Bank Q3 Preview: Profit may see sharp 39% YoY fall amid rising slippages. Nestle India Q3 Preview: Net profit may slip 9% on increased competition

Confident of adding 15-16 pumps by end-FY17: Mahanagar Gas

SM Ranade, CFO of Mahanagar Gas is also confident of margins remaining steady going forward.

Analysts raise concerns on Havells EBITDA margin post Lloyd deal

While analysts are comfortably placed with the deal‘s pricing, they have highlighted some challenges such as hit in EBITDA margins, lack of synergies, among others, for Havells that will emerge from this deal.

Capacity utilisation to go up in Bihar, W Bengal: Globus Spirits

With the facilities in West Bengal and Bihar getting commissioned there will be increase in capacity utilisation, said Shekhar Swarup, ED, Globus Spirits.

See 15-20% growth in plastic biz; Q4 to be better: Sintex

Samir Joshipura, Group CEO, Sintex is very optimistic of the plastic business growing at 15-20 percent post the demerger.

See EBITDA margins at 25% over 10 years: Glenmark CMD

The company is aiming for at least one outlicensing deal in the next year and Saldanha also feels pharma giant will grow at a 15-20 percent CAGR over the next five years.

To maintain EBITDA margins at 32%, topline 10-15%: Suven Life

Venkat Jasti, Chairman and CEO, Suven Life Sciences is confident of maintaining EBITDA margins at 32 percent or more. He is also confident of 10-15 percent topline growth in FY17 and FY18.

Healthcare Global plans to increase cancer centres to 23 from 19

Losses arising from new centres have also seen declines in the second quarter of this fiscal.

See FY17 topline growth over Rs 1100 cr: Insecticides India

Rajesh Aggarwal, Managing Director and CEO, Insecticides is confident of good growth continuing in the second half as well and expects the FY17 topline to be above Rs 1100 crore.

Wage hike to impact Q3 margins by 70 bps, Q4 by 10 bps: HCL Tech

The IT giant will be the industry leader in organic growth once it acquires the Butler America Aerospace. The acquisition will be completed by December 31 2016.

RIL blockbuster numbers to continue into H2; stock to gain: Pros

The company has shown better performance in terms of gross refining margins. Given the higher crude oil prices and their ability to source heavy duty crude at a lower price, the GRM in the third and fourth quarter should remain high, says Deven Choksey, Managing Director at KR Choksey Investment Managers.

IPO-bound Endurance focusing on margin, says cash flows strong

The company has a strong cash flow and does not need the money that would come from the IPO, said Anurang Jain, MD, Endurance Technologies.

PhillipCap has buy on Britannia with price target Rs 3050

The house currently has a target price of Rs 3050 on the stock and earnings per share estimate Rs 90 for FY18, said Jubil Jain of PhillipCapital.

Pending orders may boost revenues 15-20% in FY17: Mangalam Drugs

Govardhan Dhoot, MD, Mangalam Drugs & Organics is confident of improving revenues and growing by 15-20 percent over the last fiscal on back of pending orders.

Mining proj in Haryana to boost margins to 15-18%: High Ground

High Ground Enterprise's Sandeep Arora hopes for Rs 90-100 crore in revenues from the mining project in FY17.

Infosys, HDFC Bank, Aurobindo are top picks: R Sreesankar

R Sreesankar, Head Institutional Equities, Prabhudas Lilladher in an interview to CNBC-TV18 shared his rationale for picking Infosys, HDFC Bank, Aurobindo Pharma, Jubilant Life and Glenmark as his top picks.

Aiming for double-digit growth in next quarter: Relaxo Footwear

Talking about the outlook for the company going forward, Ramesh Kumar Dua, Managing Director, Relaxo Footwear, said they are aiming for a double-digit growth in the next quarter, with focus on sales transformation and better connection with retailers.

Targeting 11% organic revenue growth in FY17: Trigyn Tech

R Ganapathi, Chairman and Executive Director, Trigyn Technololgies is confident of maintaining strong momentum in managed services vertical.

Inox Wind Q4 Net jumps over 77% to Rs 209 crore

The consolidated income from operations during the January-March quarter increased to Rs 1,828.65 crore, over Rs 930.05 crore in the year-ago period.

No big surprises from Hero; margins may come under pressue:Pros

Hero's fourth quarter results met Street estimates. There may not be too much of positive reaction on the stock on Friday but the house has a positive bias on it, says Rahul Korde, Analyst, Prabhudas Lilladher.

Long-term debt up due to expansion: Arihant Superstructures

Aman Verma, the Chief Financial Officer of Arihant Superstructures says the key to sustainable growth is the identification of right products at right price and for right location that have higher EBITDA margins

Hold Cipla; on track to meet 20%+ EBITDA margins in'16: Religare

Praful Bohra of Religare is confident of the company clocking EBITDA margins of around 20.7 percent for FY16 and a similar number for FY17 too.

Hope to grow revenue by 20-25% in FY17: Just Dial CEO

Net profit fell 16 percent to Rs 26.99 crore year-on-year (YoY) and EBITDA margins dipped 5.15 percentage points to 26.99 percent (YoY).

Increased capacity to come on stream by year-end: Nitin Spinners

For FY17, the company has plans to increase capacities which would come on stream by year-end,said Dinesh Nolkha, Managing Director, Nitin Spinners.

Aim to reduce Rs 100 crore debt annually: Meghmani Organics

The basic chemical business is seeing very good growth because it is directly related to India‘s growth, said Ashish Soparkar, MD, Meghmani Organics, adding that the capacity utilisation for the segment is also at its optimum currently.